Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

卓捷 - NMPA Drug Approval Details

Approvals/NMPA/Meropenem for Injection

Approved

化学药品

Meropenem for Injection

北大医药股份有限公司🇨🇳 National Medical Products Administration

Approval Date: Feb 4, 2024
Approval ID: 7LeafcXpGrP
Company: 北大医药股份有限公司
Type: 化学药品

Approval Details

Approval Id: 7LeafcXpGrP
Approval Number: 国药准字H20093264
Generic Name: 注射用美罗培南
Generic Name En: Meropenem for Injection
Brand Name: 卓捷
Drug Type: 化学药品
Dosage Form: 注射剂
Strength: 0.5g(按C₁₇H₂₅N₃O₅S计)
Reg Date: 2024-02-04
Company Name: 北大医药股份有限公司
Company Address: 重庆市北碚区水土镇方正大道21号
Production Company Name: 北大医药股份有限公司;深圳市海滨制药有限公司
Production Company Address: 重庆市北碚区水土镇方正大道21号附1号；深圳市盐田区沙头角深盐路2003号
Company Detail Path: /organization/pku-healthcare-corp-ltd

Approved

Quick Info

Agency

NMPA

Country

🇨🇳

Approval Date

Feb 4, 2024

Approval ID

7LeafcXpGrP

Type

化学药品

Back to NMPA Approvals